Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
TENX

Updated 10/6/2026, 11:57 AM ET.

TENX

TENAX THERAPEUTICS, INC.

Buy$101,760

Doogan Declan

Director

53,000 shat $1.92Filed Sep 17, 9:30 PM ETFiling
TENX

TENAX THERAPEUTICS, INC.

Buy$20,087

Giordano Christopher Thomas

CEO, Director

10,850 shat $1.85Filed Sep 15, 9:38 PM ETFiling
TENX

TENAX THERAPEUTICS, INC.

Buy$10,981

STAAB THOMAS R II

Chief Financial Officer

5,675 shat $1.94Filed Sep 15, 9:30 PM ETFiling
TENX

TENAX THERAPEUTICS, INC.

Buy$1,604,160

ADAR1 Capital Management, LLC

10% owner

and 1 other

900,000 shat $1.78Filed Sep 8, 5:16 PM ETFiling
TENX

TENAX THERAPEUTICS, INC.

Buy$1,381,750

ADAR1 Capital Management, LLC

10% owner

and 1 other

770,333 shat $1.79Filed Sep 2, 5:52 PM ETFiling
TENX

TENAX THERAPEUTICS, INC.

Buy$1,814,147

ADAR1 Capital Management, LLC

10% owner

and 1 other

1,025,867 shat $1.77Filed Aug 24, 6:12 PM ETFiling

Read from public SEC filings. Not financial advice.